|
|
||||||||
Eur J Cardiothorac Surg 2001;20:443-448
© 2001 Elsevier Science NL
Division of Thoracic Surgery, University Hospital, Raemistrasse 100, CH-8091 Zurich, Switzerland
Received 10 October 2000; received in revised form 14 March 2001; accepted 19 March 2001.
Corresponding author. Tel.: +41-1-255-8802; fax: +41-1-255-8805
e-mail: walter.weder{at}chi.usz.ch
Objective: Chronic lung infection is the main indication for lobectomy in benign pulmonary disease and may be technically demanding due to inflammatory changes such as adhesions, lymph node enlargement and neovascularization. The role of the thoracoscopic operation in these indications is yet ill-defined. Methods: We retrospectively analyzed the results of patients who underwent thoracoscopic lobectomy (TL) between 1992 and June 1999 and compared this study group with patients who underwent open lobectomy (OL), all for benign disease. Data were not normally distributed, therefore, the median and range is given and nonparametric statistical analysis was applied. Results: A total of 117 lobectomies for benign disease (64 TL) were analyzed. Indications included bronchiectasis (36 TL; 18 OL), chronic infections (13 TL; eight OL), tuberculosis (five TL; 15 OL), emphysema (five TL; one OL), AV-malformations (two TL; one OL), severe haemoptysis (four OL), and others (three TL; six OL). Twelve conversions to thoracotomy were necessary due to severe adhesions. One patient in the open lobectomy group died within 30 days postoperative. Drainage time was 5.0 (132) days in TL and 6.0 (321) days in OL, hospital stay was 8.5 (441) days and 10.0 (552) days, respectively. Blood loss was 0 (02000) ml in TL and 300 (06000) ml in OL.Operation time for thoracoscopic lobectomies significantly decreased from 2.5 (16) h for cases between 1992 and 1997 (n=49) to 1.5 (0.52.5) h for recent cases (n=15) (P<0.01). In addition, a trend towards less blood loss was noted (100 (02000) ml vs. 0 (0400) ml; P=0.06). Drainage time and hospital stay did not differ significantly. Conclusions: Thoracoscopic lobectomy in chronic inflammatory disease can be performed safely in selected patients, especially with bronchiectasis. Conversion rate to thoracotomy is low. Operation time with this approach declined significantly over time.
Key Words: Video-assisted-thoracoscopic-surgery Lobectomy Benign-lung-disease
This article has been cited by other articles:
![]() |
S. Cappeliez, S. Lenoir, P. Validire, and D. Gossot Totally endoscopic lobectomy and segmentectomy for congenital bronchial atresia Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 222 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Demmy and C. Nwogu Is Video-Assisted Thoracic Surgery Lobectomy Better? Quality of Life Considerations Ann. Thorac. Surg., February 1, 2008; 85(2): S719 - S728. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Kestenholz, D. Schneiter, S. Hillinger, D. Lardinois, and W. Weder Thoracoscopic treatment of pulmonary sequestration. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 815 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Wurnig, V. Wittmer, N. S. Pridun, and P. H. Hollaus Video-Assisted Thoracic Surgery for Pleural Empyema Ann. Thorac. Surg., January 1, 2006; 81(1): 309 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Daniels, S. S. Balderson, M. W. Onaitis, and T. A. D'Amico Thoracoscopic lobectomy: a safe and effective strategy for patients with stage i lung cancer Ann. Thorac. Surg., September 1, 2002; 74(3): 860 - 864. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |